Veracyte
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veracyte and other ETFs, options, and stocks.About VCYT
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia.
CEOMarc A. Stapley
CEOMarc A. Stapley
Employees824
Employees824
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2006
Founded2006
Employees824
Employees824
VCYT Key Statistics
Market cap2.89B
Market cap2.89B
Price-Earnings ratio107.69
Price-Earnings ratio107.69
Dividend yield—
Dividend yield—
Average volume797.55K
Average volume797.55K
High today$37.07
High today$37.07
Low today$36.15
Low today$36.15
Open price$36.40
Open price$36.40
Volume861.65K
Volume861.65K
52 Week high$47.32
52 Week high$47.32
52 Week low$22.61
52 Week low$22.61
VCYT News
TipRanks 17h
Veracyte initiated with a Hold at CanaccordCanaccord analyst Kyle Mikson initiated coverage of Veracyte (VCYT) with a Hold rating and $40 price target The company’s Afirma tests for thyroid nodule classi...
Analyst ratings
83%
of 12 ratingsBuy
83.3%
Hold
8.3%
Sell
8.3%
People also own
Based on the portfolios of people who own VCYT. This list is generated using Robinhood data, and it’s not a recommendation.